Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.03
%
-1,09%
Latest
2.72
High
2.78
Low
2.7
Volume
588 091
Turnover (SEK)
1 608 186
Value (MSEK)
513,0

Board

CEO

  • Johan Drott

Chairman Of The Board

  • Christer Fåhræus

Board

  • Anna Törner
  • Ingemar Kihlström
  • Kristina Drott
  • Olov Sterner
  • Sarah Fredriksson
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Respiratorius presentation från Lund

    Hearing med Respiratorius vd

    Respiratorius - Bolagspresentation Sedermeradagen 27 mars 2014

    Föredrag av VD Johan Drott vid Stora Aktiedagen i Stockholm

    Upcoming reports

    • 2020-11-04 Delårsrapport 2020-Q3

    • 2021-02-03 Bokslutskommuniké 2020

    Annual reports, prospectus etc.

    Technical analysis

    RESP- 2019-03-07

    Technical analysis

    RESP- 2019-01-07

    Technical analysis

    RESP- 2018-07-05

    Technical analysis

    RESP- 2018-05-14